Sinovac Research and

Company snapshot

Sinovac Research and maintains 115 tracked programs across COVID-19, Poliomyelitis, Influenza, Hand, Foot and Mouth Disease, Varicella, Hepatitis A, Seasonal Influenza, Pneumococcal Infections, Pneumococcal Infectious Disease, Mumps, Infection, Viral, Enterovirus, Tetanus. Momentum score: 20/100 (30-day delta: n/a). Public registry data covers pipeline phase, clinical trials, patents, SEC filings,

• 115 active pipeline program(s) linked via ClinicalTrials.gov.
• 115 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Sinovac Research and. Not investment advice.

• Peer + 0 momentum

  SOM Biotech

  TA overlap score 22

Recent activity

Latest pipeline, patent, and corporate events for Sinovac Research and.

1. Jun 8, 2026 Clinical update

   PRO-PanFlu-4001 — Approved

2. Jun 8, 2026 Clinical update

   PRO-PVRV-sf-3003 — Phase 3

3. Jun 8, 2026 Clinical update

   PRO-QINF-4003 — Approved

4. Jun 8, 2026 Clinical update

   PRO-nCOV-2002 — Phase 2

5. Jun 8, 2026 Clinical update

   PRO-EV71/CA16-1001 — Phase 2

View all clinical trial activity →

• What is Sinovac Research and?

  SINOVAC BIOTECH (BANGLADESH) is a pharma organization headquartered in Dhaka, CN. Primary therapeutic focus areas include COVID-19, Poliomyelitis, Influenza, Hand, Foot and Mouth Disease, Varicella. NovaPharmaNews links 115 clinical program(s), 0 drug profile(s), and 0 patent rec

• Is Sinovac Research and publicly traded?

  Sinovac Research and appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Sinovac Research and develop or market?

  We link 54 drug profile(s) where Sinovac Research and is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/sinovac-biotech-ltd#company-drugs.

• What are the latest developments for Sinovac Research and?

  In the last 12 months our linked public records show 115 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Sinovac Research and focus on?

  Sinovac Research and focuses on COVID-19, Poliomyelitis, Influenza based on our analysis of their pipeline programs and drug development activities.